glutathione and breat cancer cells Mitochondrial import identified as key driver of breast spread Mitochondrial glutathione, imported via the SLC25A39 transporter, is essential for breast cancer metastasis, particularly during early colonization of new tissues. Elevated Glutathione and Thioredoxin Antioxidant Pathways

Its value is in what it adds when combined with GLP-1 agonism

Dosing Recommendations While human clinical trial data remains limited, current evidence-based recommendations derived from animal studies and clinical experience suggest: General anti-inflammatory dosing: 200-500 mcg administered subcutaneously once daily or 500-1000 mcg twice weekly Acute injury management: Higher doses (500-1000 mcg) may be used daily initially, with tapering to maintenance doses Route of administration: Both systemic (subcutaneous/intramuscular) and local (perilesional) injections have shown similar efficacy

Based on clinical trial data, the maximum studied weekly dose of cagrilintide is 2.4 mg when combined with GLP-1 receptor agonists

doi: 10.1016/j.mce.2013.05.014 105 UmlandSPSchleimerRPJohnstonSL

Figure 5 shows that the effect of vitamin B 12 on GSH is very weak in the model: Changes in do not percolate systematically to changes in GSH

doi: 10.1038/sj.jhh.1001964 128 WiciskiMWdkiewiczEGrskiKWalczakMMalinowskiB